Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Tracing Senate bill S. 5812 would permanently extend HHS authority to award priority review vouchers for rare pediatric disease products, and was referred to the HELP Committee on 2026-11-19.×Refreshed just now
All24 hours
× Show allIn focus

Navy touts shorter submarine maintenance delays as CBO questions AUKUS sub sales

Navy submarine czar Vice Adm. Rob Gaucher says maintenance delays fell by over 600 days in FY26 and that delivering the first Columbia-class boat in 2028 is achievable. NAVSEA awarded Fairbanks Morse Defense a roughly $100 million follow-on contract for emergency diesel generator overhauls on six Los Angeles- and Ohio-class boats. A CBO finding that AUKUS sales would shrink the US attack submarine fleet for many years adds pressure on production and sustainment capacity. No upcoming hearings or deadlines appear in the items. · 2d ago

Forces, money & more Defense

Activity · 30 days back, 14 ahead

Total
4
Peak/day
1Nov 5
7d
1▼1
Next
—
Σ/day1
Hill0
Contracts0
News4

In the News

One card per story, every outlet that covered it
25
  1. 4d agoYahooWhite House pulls FDA nominee Heidi Overton after wavering support from Senate RepublicansSTAT's Readout Loud podcast episode covers the Trump administration withdrawing Heidi Overton's FDA commissioner nomination, the FDA's rejection of Summit Therapeutics and Akeso's lung cancer drug, and STAT's new index ranking China's largest drugmakers.
    4 articles · 2 outlets
    1. 4d agoSTATSTAT+: White House pulls nomination of Heidi Overton to lead FDA
    2. 4d agoYahooPickupWhite House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans
    3. 3d agoSTATSTAT+: 7 burning questions about the FDA’s post-Overton future
    4. 2d agoSTATEarliestFDA’s search for a new leader, and China’s largest drugmakers
    Biotech66 linked
  2. 3d agoFortuneThe midterms weren’t really about data centers. An AI researcher says voters want a pause on AI itselfFortune argues that Democrats, having won on anger over AI data centers and power bills, need to weigh moratoriums, congressional oversight, state utility cost rules, and tech-industry deals against the economic value of AI investment.
    2 articles
    1. 5d agoFortuneEarliestVoters want relief from rising power bills. Democrats must find a way to deliver without stalling the AI investment helping drive the economy
    2. 3d agoFortunePickupThe midterms weren’t really about data centers. An AI researcher says voters want a pause on AI itself
    AIVoters back data center limits as states and counties move to pause projects56 linked
  3. 13d agoThe GuardianWe can’t just ‘move on’: Democrats must hold Trump accountable | Jan-Werner MüllerA Guardian opinion column urges Democrats, fresh from midterm wins, to hold the Trump administration accountable through testimony, impeachment and legal action rather than moving on.
    2 articles
    1. 13d agoThe GuardianEarliestWe can’t just ‘move on’: Democrats must hold Trump accountable | Jan-Werner Müller
    2. 13d agoThe GuardianPickupTime to fight back: five leading thinkers on what Democrats should do post-midterms
    Democrats plan House oversight probes as Blanche won't rule out charges against Garcia13 linked
  4. Nov 4Semafor‘Out for blood’: Investigations overshadow dealmaking in newly divided WashingtonSemafor reports that corporate America is readying executives for likely post-midterm Democratic congressional scrutiny over business dealings that courted President Trump.
    7 articles
    1. Nov 2SemaforDemocrats weigh ‘lawfare’ against Trump
    2. Nov 2SemaforPickupDemocrats eye post-election powers
    3. Nov 3SemaforEarliestCorporate America prepares for post-midterm Democratic backlash
    4. Nov 4SemaforDemocrats turn scrutiny to tech CEOs and Trump officials
    5. Nov 4SemaforPickupDemocrats to focus on affordability and corruption probes
    6. Nov 4Semafor‘Out for blood’: Investigations overshadow dealmaking in newly divided Washington
    7. Nov 6SemaforDemocrats’ CEO targets remain a work in progress
    Democrats plan House oversight probes as Blanche won't rule out charges against Garcia51 linked

On the Hill

Congress, the White House and agencies
13

Ahead

Recent

Wednesday, Mar 18

Times ET

Contracts

Solicitations, SBIR topics, grants and awards
3

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy